跳至主要内容
临床试验/CTRI/2026/03/106217
CTRI/2026/03/106217尚未招募2/3 期

AN INTERVENTIONAL STUDY TO ASSESS THE EFFECTIVENESS OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

National Institute of Delhi1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2026年3月21日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
38
试验地点
1

研究概览

简要总结

ype 2 Diabetes Mellitus T2DM is a chronic metabolic disorder characterized by persistent hyperglycaemia due to insulin resistance and progressive beta cell dysfunction. The global prevalence of diabetes is increasing rapidly and poses a major public health challenge due to its long term complications affecting the eyes kidneys nerves and cardiovascular system. Homoeopathy follows a holistic and individualized approach in which medicines are prescribed based on the totality of symptoms of the patient.

The present study aims to evaluate the effect of individualized homoeopathic treatment in patients with Type 2 Diabetes Mellitus. This will be a single arm interventional clinical study conducted at the National Institute of Homoeopathy Narela. A total of 38 newly diagnosed patients aged 35 to 65 years will receive individualized homoeopathic medicines along with dietary and lifestyle advice. Outcomes will be assessed by comparing fasting blood sugar FBS post prandial blood sugar PPBS HbA1c and Diabetes Quality of Life DQOL scores at baseline and after three months of treatment. Statistical analysis will be performed to evaluate changes in glycaemic control following treatment.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
35.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Newly diagnosed cases Diagnosed Type 2 Diabetes Mellitus who have a Blood FBS More than 126mg/dl upto 200mg/dl & Post prandial plasma glucose 200-300 mg/dl.
  • Newly diagnosed cases Diagnosed Type 2 Diabetes Mellitus who have a HbA1C 6.5-8.5 Willing patients who will give their written consent for the study.

排除标准

  • Patients with Type 1 diabetes and complications of type 2 diabetes mellitus .Pregnant or lactating women.
  • Patients with serious systemic disorders or life-threatening infections e.g CKD, CAD.
  • Patients who are taking medicine from other system.

研究者

发起方
National Institute of Delhi
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Kapil Raman

National Institute of Homoeopathy Delhi

研究点 (1)

Loading locations...

相似试验